Status:
COMPLETED
Testosterone Treatment for Hypogonadal Men
Lead Sponsor:
Abbott
Conditions:
Hypogonadism
Eligibility:
MALE
18-80 years
Phase:
PHASE3
Brief Summary
Demonstrate efficacy and safety of Testosterone Gel 1.62% for the treatment of hypogonadal men
Eligibility Criteria
Inclusion
- Low T males 18 - 80 years of age
Exclusion
- Normal T levels
- Elevated Prostatic Specific Antigen (PSA)
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
274 Patients enrolled
Trial Details
Trial ID
NCT00433199
Start Date
February 1 2007
End Date
April 1 2008
Last Update
January 27 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.